Results 1 to 10 of about 3,180,787 (344)

Heart Transplantation From DCD Donors in Australia: Lessons Learned From the First 74 Cases

Transplantation, 2022
Heart transplantation from donation after circulatory death (DCD) donors has the potential to substantially increase overall heart transplant activity.
Y. Joshi, S. Scheuer, H. Chew, Min Ru Qiu, C. Soto, J. Villanueva, Ling Gao, A. Doyle, Shingo Takahara, C. Jenkinson, N. Vaidhya, Yorihiko Matsumoto, Bridget Hwang, Christine Zhao, A. Iyer, M. Connellan, A. Watson, E. Granger, K. Muthiah, A. Jabbour, E. Kotlyar, A. Keogh, Nicole K. Bart, C. Hayward, K. Dhital, P. Jansz, P. Macdonald   +26 more
semanticscholar   +1 more source

Current status and outcomes in heart transplantation: a narrative review.

Reviews in cardiovascular medicine, 2022
The first human heart transplantation was performed by Christian Barnard in 1967. While the technical aspect had been worked out, allograft rejection was a major limitation in the early days of heart transplant.
Morcos A. Awad, Aakash Shah, B. Griffith
semanticscholar   +1 more source

Exercise training in heart transplantation

World journal of transplantation, 2021
Heart transplantation remains the gold standard in the treatment of end-stage heart failure (HF). Heart transplantation patients present lower exercise capacity due to cardiovascular and musculoskeletal alterations leading thus to poor quality of life ...
C. Kourek, E. Karatzanos, S. Nanas, A. Karabinis, S. Dimopoulos   +4 more
semanticscholar   +1 more source

Cell Therapy in Heart Failure with Preserved Ejection Fraction

Cardiac Failure Review, 2022
Heart failure with preserved ejection fraction (HFpEF) is the most common cause of hospitalisation for heart failure. However, only limited effective treatments are available. Recent evidence suggests that HFpEF may result from a systemic proinflammatory
Sabina Frljak, Gregor Poglajen, Bojan Vrtovec   +2 more
doaj   +1 more source

A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation

Nature Communications, 2020
Pre-clinical heart transplantation studies have shown that ex vivo non-ischemic heart preservation (NIHP) can be safely used for 24 h. Here we perform a prospective, open-label, non-randomized phase II study comparing NIHP to static cold preservation ...
J. Nilsson, V. Jernryd, G. Qin, A. Paskevicius, C. Metzsch, T. Sjöberg, S. Steen   +6 more
semanticscholar   +1 more source

Consensus conference on heart‐kidney transplantation

American Journal of Transplantation, 2021
Simultaneous heart‐kidney transplant (sHK) has enabled the successful transplantation of patients with end‐stage heart disease and concomitant kidney disease, with non‐inferior outcomes to heart transplant (HT) alone.
J. Kobashigawa, D. Dadhania, M. Farr, W. Tang, A. Bhimaraj, L. Czer, S. Hall, A. Haririan, R. Formica, J. Patel, R. Skorka, S. Fedson, T. Srinivas, J. Testani, J. Yabu, X. Cheng, Eric Adler, Enver Akalin, Allen Anderson, K. Birdwell, David J. Cohen, R. Crew, Howard Eisen, Erika Feller, Bernie Fischbach, Lorenzo Gallon, Alan Gass, Juan Gonzalez, Evelyn Horn, Lesley Inker, Maryl Johnson, K. Khush, Heather Lefkowitz, Abdul Moiz, S. Nathan, A. Nsair, Alice Peng, Emilio Poggio, R. Radovancevic, Ashwin Ravichandran, D. Serur, Mark Zucker   +41 more
semanticscholar   +1 more source

Post-Myocardial Infarction Ventricular Septal Defect Successfully Treated with Impella as Bridge to Cardiac Transplantation

Case Reports in Cardiology, 2022
A 63-year-old female presented late with anterior ST-elevation myocardial infarction and cardiogenic shock. This was complicated by acute ventricular septal defect with large left-to-right shunt.
Lauren Giudicatti, Benjamin Silbert, Xiao-Fang Xu, Anthony Putrino, Felicity Lee, Amit Shah, Robert Larbalestier, Karim Slimani, Andrew Laycock, Kaitlyn Lam   +9 more
doaj   +1 more source

ERRATUM: A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant

Hematology Reports, 2020
Due to an error, Dr. Nikolousis’s last name was mistakenly spelled in this article (published in 2019 in Hematology Reports DOI: 10.4081/hr.2019.7800). The correct author’s name appears above in italics.
Claire Horgan, Alexandros Kanellopoulos, Shankara Paneesha, Bhuvan Kishore, Richard Lovell, Emmanouil Nikolousis   +5 more
doaj   +1 more source

Dissection of descending aorta treated by stent-graft implantation in a patient with Marfan syndrome

Heart Vessels and Transplantation, 2017
This report describes a 32 years old patient with Marfan syndrome and hypertension. David`s procedure was performed to the patient three months before due to dissection of the ascending thoracic aorta.
Marat A. Aripov, Ildar Z. Abdyldaev, Semen D. Schevgun , Bektur S. Daniyarov, Dinara B. Toktosunova, Azamat M. Sarbaev   +5 more
doaj   +1 more source

Ethnic disparity in Israel impacts long-term results after heart transplantation

Israel Journal of Health Policy Research, 2019
Background Ethnicity may affect graft longevity and recipient mortality after heart transplantation (HTx). We hypothesized that differences in ethnic origin between Arabs and Jews undergoing HTx in Israel may contribute to differences in long-term ...
Yael Peled, Ron Loewenthal, Yigal Kassif, Eugenia Raichlin, Arwa Younis, Anan Younis, Eyal Nachum, Dov Freimark, Jacob Lavee   +8 more
doaj   +1 more source